Literature DB >> 18380619

Bilateral pubic and ischial osteotomy for surgical management of caudal colonic and rectal masses in six dogs and a cat.

Hun-Young Yoon1, F A Mann.   

Abstract

CASE DESCRIPTION: 6 dogs and a cat were evaluated because of caudal colonic and rectal masses. CLINICAL
FINDINGS: Tumors were identified in the caudal portion of the colon (n = 2), in the area of the colorectal junction (2), or in the rectum (3). TREATMENT AND OUTCOME: In all 7 animals, bilateral pubic and ischial osteotomy was performed to provide exposure of the rectum and associated tumor. Masses were successfully removed, and all 7 animals were able to ambulate normally within 3 days after surgery. No complications associated with the osteotomy procedure were identified. CLINICAL RELEVANCE: Findings suggested that bilateral pubic and ischial osteotomy provided sufficient exposure for resection of intrapelvic tumors in dogs and a cat with minimal complications.

Entities:  

Mesh:

Year:  2008        PMID: 18380619     DOI: 10.2460/javma.232.7.1016

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  3 in total

1.  Pubectomy and stereotactic radiotherapy for the treatment of a non-resectable sacral osteosarcoma causing pelvic canal obstruction in a dog.

Authors:  Victoria D Randall; Sarah E Boston; Heather L Gardner; Lynn Griffin; Michelle L Oblak; Lyndsay Kubicek
Journal:  Can Vet J       Date:  2016-09       Impact factor: 1.008

2.  Complete vaginectomy via a ventral approach with pelvic osteotomy in a cat.

Authors:  Yuya Saitoh; Takeshi Aikawa; Yuta Miyazaki
Journal:  Can Vet J       Date:  2022-07       Impact factor: 1.075

3.  Submucosal resection via a transanal approach for treatment of epithelial rectal tumors - a multicenter study.

Authors:  Matteo Cantatore; Juan Carlos Jimeno Sandoval; Smita Das; Alberto Sesana; Tim Charlesworth; Tony Ryan; Emanuela M Morello; Matteo Gobbetti; Filippo Cinti; Matteo Rossanese
Journal:  Vet Surg       Date:  2022-01-08       Impact factor: 1.618

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.